• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种血浆中携带的人雌激素敏感性乳腺肿瘤细胞增殖的特异性抑制剂(雌激素抑素-I)。

A plasma-borne specific inhibitor of the proliferation of human estrogen-sensitive breast tumor cells (estrocolyone-I).

作者信息

Soto A M, Silvia R M, Sonnenschein C

机构信息

Tufts University Health Science Schools, Department of Anatomy and Cellular Biology, Boston, MA 02111.

出版信息

J Steroid Biochem Mol Biol. 1992 Dec;43(7):703-12. doi: 10.1016/0960-0760(92)90296-u.

DOI:10.1016/0960-0760(92)90296-u
PMID:1472462
Abstract

Charcoal-dextran stripped serum/plasma supplemented media specifically inhibit the proliferation of estrogen-sensitive cells in culture conditions; estrogens cancel this effect. Here, we further characterize this phenomenon using human estrogen-sensitive breast cancer MCF7 cells and human serum/plasma. The serum/plasma-borne inhibitory activity (estrocolyone-I) is a non-dialyzable, heat-stable (60 degrees C x 2 h), protease-sensitive macromolecule and it is not extractable by organic solvents. Estrocolyone-I activity is retained after dialysis against 6 M urea or 10-100 mM dithiothreitol; however, simultaneous treatment with 6 M urea and 10-100 mM dithiothreitol completely abolishes its inhibitory activity. The inhibitory effect of serum is not due to serum albumin, nor to estrogen trapping by albumin or by sex hormone-binding globulin. Substantial purification was achieved by a combination of chromatographic techniques (dye-affinity, ion exchange, hydrophobic interaction chromatography). Estrocolyone-I activity seems to be due to a protein of an apparent native Mw of 70-80 kDa and an isoelectric point of 4.5-4.8.

摘要

用木炭 - 葡聚糖去除血清/血浆补充的培养基在培养条件下能特异性抑制雌激素敏感细胞的增殖;雌激素可消除这种作用。在此,我们使用人雌激素敏感的乳腺癌MCF7细胞和人血清/血浆进一步表征这一现象。血清/血浆携带的抑制活性(雌激素抑制素 - I)是一种不可透析、热稳定(60℃×2小时)、对蛋白酶敏感的大分子,且不能被有机溶剂提取。在对6M尿素或10 - 100mM二硫苏糖醇进行透析后,雌激素抑制素 - I活性得以保留;然而,同时用6M尿素和10 - 100mM二硫苏糖醇处理会完全消除其抑制活性。血清的抑制作用并非由于血清白蛋白,也不是由于白蛋白或性激素结合球蛋白对雌激素的捕获。通过多种色谱技术(染料亲和、离子交换、疏水相互作用色谱)的组合实现了大量纯化。雌激素抑制素 - I活性似乎归因于一种表观天然分子量为70 - 80kDa且等电点为4.5 - 4.8的蛋白质。

相似文献

1
A plasma-borne specific inhibitor of the proliferation of human estrogen-sensitive breast tumor cells (estrocolyone-I).一种血浆中携带的人雌激素敏感性乳腺肿瘤细胞增殖的特异性抑制剂(雌激素抑素-I)。
J Steroid Biochem Mol Biol. 1992 Dec;43(7):703-12. doi: 10.1016/0960-0760(92)90296-u.
2
Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells.
J Steroid Biochem Mol Biol. 1996 Oct;59(2):147-54. doi: 10.1016/s0960-0760(96)00112-4.
3
Estrogen-sensitive proliferation pattern of cloned Syrian hamster kidney tumor cells.
Cancer Res. 1988 Jul 1;48(13):3676-80.
4
Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.雌激素的促有丝分裂作用。二、对源自人和啮齿动物靶组织肿瘤的细胞系类固醇激素反应性生长的负调控及概念意义。
In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):428-46. doi: 10.1290/1071-2690(2000)036<0428:EMAINR>2.0.CO;2.
5
Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants.
Oncol Res. 1994;6(8):373-81.
6
Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells.雌激素对细胞增殖的作用机制:对克隆化乳腺肿瘤细胞间接和负向调控的证据
Biochem Biophys Res Commun. 1984 Aug 16;122(3):1097-103. doi: 10.1016/0006-291x(84)91204-x.
7
Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF7 human breast tumor cells.他莫昔芬及其衍生物对MCF7人乳腺癌细胞增殖的雌激素样作用。
Life Sci. 1985 Jul 29;37(4):387-94. doi: 10.1016/0024-3205(85)90510-7.
8
Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.雌激素的促有丝分裂作用。I. 在补充血清的培养中雌激素依赖性MTW9/PL2致癌物诱导的大鼠乳腺肿瘤细胞生长的证明及技术意义。
In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):410-27. doi: 10.1290/1071-2690(2000)036<0410:EMAIDO>2.0.CO;2.
9
A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification.
J Natl Cancer Inst. 1984 Feb;72(2):291-8.
10
Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum.在经活性炭处理的成年牛血清商业制剂中对MCF-7乳腺癌细胞增殖的控制
Breast Cancer Res Treat. 1992;23(1-2):97-104. doi: 10.1007/BF01831481.

引用本文的文献

1
Characterization of MCF-12A cell phenotype, response to estrogens, and growth in 3D.MCF-12A细胞表型、对雌激素的反应及三维生长特性
Cancer Cell Int. 2018 Mar 20;18:43. doi: 10.1186/s12935-018-0534-y. eCollection 2018.
2
Induction of cytochrome P4501A and endocrine disrupting effects of school incinerator residues.学校垃圾焚烧炉残渣对细胞色素P4501A的诱导及内分泌干扰作用。
Environ Monit Assess. 2003 Mar;83(1):35-45. doi: 10.1023/a:1022402719842.
3
Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
雌激素的促有丝分裂作用。二、对源自人和啮齿动物靶组织肿瘤的细胞系类固醇激素反应性生长的负调控及概念意义。
In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):428-46. doi: 10.1290/1071-2690(2000)036<0428:EMAINR>2.0.CO;2.
4
Developing a marker of exposure to xenoestrogen mixtures in human serum.开发一种人体血清中异雌激素混合物暴露的标志物。
Environ Health Perspect. 1997 Apr;105 Suppl 3(Suppl 3):647-54. doi: 10.1289/ehp.97105s3647.
5
The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants.作为识别雌激素工具的E-SCREEN检测法:雌激素性环境污染物的最新情况
Environ Health Perspect. 1995 Oct;103 Suppl 7(Suppl 7):113-22. doi: 10.1289/ehp.95103s7113.
6
The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells.农药硫丹、毒杀芬和狄氏剂对人类雌激素敏感细胞具有雌激素效应。
Environ Health Perspect. 1994 Apr;102(4):380-3. doi: 10.1289/ehp.94102380.